Skip to main content
Top

Current Cardiology Reports

Issue 2/2007

Content (13 Articles)

Are vasodilators still indicated in the treatment of severe aortic regurgitation?

  • Valvular Heart Disease

Jocelyn Inamo, Maurice Enriquez-Sarano

What is the proper place of the ross procedure in our modern armamentarium?

  • Valvular Heart Disease

Duke E. Cameron, Luca A. Vricella

Reassessment of statins to retard the progression of aortic stenosis

  • Valvular Heart Disease

Nalini M. Rajamannan

A practical approach to the quantification of valvular regurgitation

  • Valvular Heart Disease

Ron Jacob, William J. Stewart

The management of functional mitral regurgitation

  • Valvular Heart Disease

Blase A. Carabello

Methodology for quantifying absolute myocardial perfusion with PET and SPECT

  • Nuclear Cardiology

Martin A. Lodge, Frank M. Bengel

Myocardial metabolism and cardiac performance in obesity and insulin resistance

  • Nuclear Cardiology

Stacy Banerjee, Linda R. Peterson

The role and regulation of cardiac angiotensin-converting enzyme for noninvasive molecular imaging in heart failure

  • Nuclear Cardiology

Omer Aras, Steven A. Messina, Jamshid Shirani, William C. Eckelman, Vasken Dilsizian

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME